All Clinical Trial - Project Baseline Health Study

Status Active, not recruiting

Clinical Trial Summary

This study is the first initiative of Project Baseline, a broader effort designed to develop a well-defined reference, or "baseline," of good health as well as a rich data platform that may be used to better understand the transition from health to disease and identify additional risk factors for disease. Project Baseline endeavors to test and develop new tools and technologies to collect, organize, and activate health information.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03154346
Study type	Observational [Patient Registry]
Source	Baseline Study LLC
Contact
Status	Active, not recruiting
Phase
Start date	March 29, 2017
Completion date	December 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05016947` - Venetoclax Plus Inotuzumab for B-ALL	Phase 1
Recruiting	`NCT05009537` - Optical Genome Mapping in Hematological Malignancies
Terminated	`NCT01230788` - Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia	N/A
Completed	`NCT00333190` - CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation	N/A
Recruiting	`NCT05461625` - ACL Reconstruction With/Without ALL Reconstruction	N/A
Recruiting	`NCT02990572` - Amish/Mennonite Research Contact Registry
Completed	`NCT02631993` - Photochemotherapy and Graft-versus-leukemia in Acute-leukemia	N/A
Completed	`NCT00863148` - Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)	Phase 2
Recruiting	`NCT04601584` - GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL	Phase 1/Phase 2
Not yet recruiting	`NCT05592470` - commd7 Gene Expression in ALL
Recruiting	`NCT02861209` - Collaborative Network to Take Responsibility for Oral Anticancer Therapy	N/A
Completed	`NCT01012492` - Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT	Phase 2
Recruiting	`NCT04644016` - Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders	Phase 2
Recruiting	`NCT06131801` - Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Recruiting	`NCT05476770` - Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies	Phase 1
Recruiting	`NCT03571321` - Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia	Phase 1
Recruiting	`NCT05414162` - Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy
Terminated	`NCT01532635` - A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives	Phase 2
Completed	`NCT01319864` - POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients	Phase 1
Completed	`NCT00013533` - Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies	Early Phase 1